ProCE Banner Activity

When and How to Assess Genomic and Molecular Alterations in AML: Which Mutations Matter?

Slideset Download
Eunice S. Wang, MD, highlights the importance of biomarkers and MRD testing for optimal treatment of patients with AML.

Released: December 06, 2019

Expiration: December 04, 2020

No longer available for credit.

Share

Faculty

Eunice S. Wang

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by educational grants from

Actinium

Boston Biomedical

Jazz Pharmaceuticals Inc

Pfizer, Inc.

Partners

NCCN

ProCE Banner

Faculty Disclosure

Primary Author

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York